Norflurane

Norflurane

SCHEMBL6464542

Cl.FCC(F)(F)F

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Norflurane. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Norflurane SCHEMBL28923104 0.95
Norflurane SCHEMBL1173735 0.94
Norflurane SCHEMBL9499 0.94
Norflurane SCHEMBL11036325 0.94
Norflurane SCHEMBL5466910 0.94
Norflurane SCHEMBL25284988 0.89
Norflurane SCHEMBL6113625 0.89
Norflurane SCHEMBL11502390 0.89
Norflurane SCHEMBL14482028 0.89
Norflurane SCHEMBL4249722 0.89

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1810256-A Policresulen foam aerosol and its prepn process SHANDONG JINGWEI PHARMACEUTICA (CN) 2006-08-02 CN claimed
EP-1350564-A1 Fluorination catalyst and process Ineos Fluor Holdings Limited (GB) 2003-10-08 EP claimed
EP-0605683-B1 PRODUCTION OF TETRAFLUOROETHANES ICI PLC (GB) 1997-09-03 EP claimed
US-5623092-A ZINC PROMOTED CHROMIA-TYPE CATALYST IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1997-04-22 US claimed
EP-0502605-B1 Fluorination catalyst and process ICI PLC (GB) 1996-07-17 EP claimed
EP-0666105-A2 Fluorination catalyst and process IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1995-08-09 EP claimed
EP-0502605-A1 Fluorination catalyst and process IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1992-09-09 EP claimed
CN-101502510-B Medicament composition for treating colpitis symptoms and preparation method thereof JEWIM PHARMACEUTICAL SHANDONG CO LTD 2011-11-09 CN disclosed
CN-101186807-B Mixed refrigerant GUANGDONG CHEERY AIR CONDITIONER MFG CO LTD 2011-01-26 CN disclosed
CN-101735773-A High-temperature heat pump mixed working medium CHUNBAO PAN 2010-06-16 CN disclosed
CN-101502510-A Medicament composition for treating colpitis symptoms and preparation method thereof SHANDONG JEWIM PHARMACEUTICAL (CN) 2009-08-12 CN disclosed
CN-101186807-A Mixed refrigerant GUANGDONG CHEERY AIR CONDITION (CN) 2008-05-28 CN disclosed
CN-1972968-A Method for separating slurry components EXXONMOBIL CHEM PATENTS INC (US) 2007-05-30 CN disclosed
EP-1350564-A1 Fluorination catalyst and process Ineos Fluor Holdings Limited (GB) 2003-10-08 EP disclosed
US-5623092-A ZINC PROMOTED CHROMIA-TYPE CATALYST IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1997-04-22 US disclosed
EP-0502605-B1 Fluorination catalyst and process ICI PLC (GB) 1996-07-17 EP disclosed
US-5449656-A Fluorination catalyst and process IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1995-09-12 US disclosed
EP-0666105-A2 Fluorination catalyst and process IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1995-08-09 EP disclosed
US-5281568-A Chromium zinc oxide catalyst IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1994-01-25 US disclosed
EP-0502605-A1 Fluorination catalyst and process IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1992-09-09 EP disclosed